|
A dedicated facility for Cephalosporin is currently under construction.
3000 sqm floor plan building and 2800 sqm area for product and material storage and mezzanine floors for technical utilities area.
The facility has been designed to conform to the requirements of international standards including WHO (Geneva), PIC/s, EU GMP Annexure 1, and current Good
Manufacturing Practices in pharmaceutical industries.
The facility is planned to be operationalised in 2 stages:
Stage 1: Sterile dry injectable powder: The facility is likely to become operational for qualification
by Jan 2016. Commercial manufacture is planned from Mar 2016. The new automatic in-line machineries are capable
of producing an estimated 50 million vials per year
and conforms to all current cGMP guidelines. Utilities including purified water, water for injection and a pure steam system are installed and operated in
accordance with WHO requirements and the latest guidelines and regulations set by EP, USP and other international pharmacopoeias.
Stage 2: Oral Cephalosporins: the unit is
likely to start manufacture from Jan 2017.
PRODUCTS.... |
All Rights Reserved by Pharmanza (India) Pvt Ltd. Only- 2011 |